Flow Traders U.S.’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,528
Closed -$368K 1344
2025
Q3
$368K Buy
+11,528
New +$364K 0.01% 686
2025
Q2
Sell
-27,628
Closed -$783K 1329
2025
Q1
$783K Buy
27,628
+19,659
+247% +$617K 0.03% 466
2024
Q4
$235K Buy
+7,969
New +$237K 0.01% 843
2022
Q1
Sell
-28,070
Closed -$1.39M 1044
2021
Q4
$1.39M Buy
28,070
+17,771
+173% +$920K 0.07% 216
2021
Q3
$548K Sell
10,299
-1,256
-11% -$69.4K 0.02% 672
2021
Q2
$669K Buy
11,555
+6,820
+144% +$388K 0.03% 509
2021
Q1
$272K Buy
+4,735
New +$290K 0.01% 681

Other funds holding HEAL

Flow Traders U.S.'s HEAL Position: Q4 2025 in Review

Flow Traders U.S. sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2025, closing a stake of 11,528 shares — an estimated $368K sold.

Flow Traders U.S. first reported a position in HEAL in Q1 2021 and held it in 7 quarters. The position peaked at $1.39M in Q4 2021. 28 funds tracked by Wall St. Rank hold HEAL as of Q4 2025.

  • Flow Traders U.S. reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2025 after selling out during the quarter.
  • Flow Traders U.S. sold 11,528 Global X Funds Global X HealthTech ETF shares in Q4 2025, an estimated $368K.
  • Flow Traders U.S. first reported a position in Global X Funds Global X HealthTech ETF in Q1 2021 and held it in 7 quarters.
  • Flow Traders U.S.'s Global X Funds Global X HealthTech ETF position peaked at $1.39M in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2025.

Based on Flow Traders U.S.'s 13F filing for Q4 2025, filed 13 Feb 2026.